June 16, 2024

Mikayla Macfarlane

Serving technology better

Spinal implant allows Parkinson’s patient to walk for miles

3 min read
Swiss neurosurgeon, professor and co-director of NeuroRestore Jocelyne Bloch (L) and Swiss professor of neuroscience at the Swiss Federal Institute of Technology in Lausanne (EPFL) Lausanne University Hospital (CHUV) and Lausanne University (UNIL) and co-director of NeuroRestore, Gregoire Courtine (R), walk with Marc (C) a French patient suffering from Parkinson's disease fitted with a new neuroprosthesis during the presentation of a new neuroprosthesis that restores fluid walking in Lausanne, on November 3, 2023. Neuroscientists from Inserm, CNRS and the University of Bordeaux in France, together with Swiss researchers and neurosurgeons (EPFL/CHUV/UNIL), have designed and tested a 'neuroprosthesis' designed to correct the walking problems associated with Parkinson's disease. (Photo by GABRIEL MONNET / AFP) /


A Parkinson’s patient can now walk 6km (3.7 miles) thanks to an implant targeting the spinal cord. The Guardian reports that the man — 62-year-old “Marc” from Bordeaux, France — developed severe mobility impairments from the degenerative disease. “I practically could not walk anymore without falling frequently, several times a day,” he said in a press release announcing the breakthrough. “In some situations, such as entering a lift, I’d trample on the spot, as though I was frozen there, you might say.” Wearing the spinal implant allows him to walk “almost normally” as the research team eyes a full clinical trial.

Marc underwent a “precision neurosurgical procedure” two years ago at Lausanne University Hospital (CHUV), which helped facilitate the research. The surgery fitted him with an electrode field placed against his spinal cord and an electrical impulse generator under the skin of his abdomen. Although conventional Parkinson’s treatments often target brain regions affected by the loss of dopamine-producing neurons, this approach instead focuses on the spinal area associated with activating leg muscles for walking.

The procedure used a personalized map of Marc’s spinal cord, identifying the specific locations signaling leg movements. He wears a movement sensor on each leg that tells the implant he’s trying to walk; it then switches on and sends electrical impulses to the targeted spinal neurons, adapting to his movement in real-time.

Swiss neurosurgeon, professor and co-director of NeuroRestore Jocelyne Bloch (L) and Swiss professor of neuroscience at the Swiss Federal Institute of Technology in Lausanne (EPFL) Lausanne University Hospital (CHUV) and Lausanne University (UNIL) and co-director of NeuroRestore, Gregoire Courtine (R), walk with Marc (C) a French patient suffering from Parkinson's disease fitted with a new neuroprosthesis during the presentation of a new neuroprosthesis that restores fluid walking in Lausanne, on November 3, 2023. Neuroscientists from Inserm, CNRS and the University of Bordeaux in France, together with Swiss researchers and neurosurgeons (EPFL/CHUV/UNIL), have designed and tested a 'neuroprosthesis' designed to correct the walking problems associated with Parkinson's disease. (Photo by GABRIEL MONNET / AFP) /
GABRIEL MONNET via Getty Images

“In response to precise stimulation of the lumbar spinal cord, I’ve observed for the first time remarkable improvements of gait deficits due to Parkinson’s disease,” project supervisor Jocelyne Bloch, professor and neurosurgeon at CHUV Lausanne University hospital, said in a webinar discussing the patient’s success. “I really believe that these results open realistic perspectives to develop a treatment.”

The patient says he could walk practically normally with the stimulation after several weeks of rehab. He now wears it for around eight hours daily, only turning it off when sleeping or lying down for a while. “I turn on the stimulation in the morning and I turn off in the evening,” he said. “This allows me to walk better and to stabilise. Right now, I’m not even afraid of the stairs anymore. Every Sunday I go to the lake, and I walk around 6 kilometres. It’s incredible.”

The researchers caution that there’s still a vast chasm between tailoring the approach to one person vs. optimizing it for wide-scale use. Co-leads Grégoire Courtine and Bloch are working on a commercial version of the neuroprosthetic in conjunction with Onward Medical. “Our ambition is to provide general access to this innovative technology to improve the quality of life of Parkinson’s patients significantly, all over the world,” they said.

Sting (left) and Michael J. Fox jam on guitars onstage at a 2021 benefit.
Michael J. Fox (right) with Sting.
Michael J. Fox Foundation

In the meantime, research on six new patients will continue in 2024. The team says a “generous donation” of $1 million from the Michael J. Fox Foundation for Parkinson’s Research is funding the upcoming work. In 2021, the actor’s organization announced it had contributed over $1.5 billion to Parkinson’s research.

This article originally appeared on Engadget at https://www.engadget.com/spinal-implant-allows-parkinsons-patient-to-walk-for-miles-193637427.html?src=rss



Source link

Copyright © All rights reserved. | Newsphere by AF themes.